Back to search

University of South Florida

SARS-CoV-2 Neurotropism: Understanding Effects at the Blood-Brain Barrier and Hematogenous Neuroinvasiveness

Abstract

dc:description

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19, has provisional counts of over 110 million documented cases and 1.218 million deaths (as of February 2024) in the United States since January 2020. SARS-CoV-2 is an airborne respiratory virus that primarily infects the lungs via the ACE2 receptor but has well-documented secondary target organs including the kidneys, the gastrointestinal tract, the heart, and the skin. SARS-CoV-2 also infects the brain, but the hematogenous route of viral entry to brain is still not fully characterized. Understanding how SARS-CoV-2 traverses the blood-brain barrier (BBB) as well as how it affects the molecular functions of the BBB are unclear. In this study, we investigated the roles of the receptors angiotensin converting enzyme 2 (ACE2) and dipeptidyl peptidase 4 (DPP4) in SARS-CoV-2 infection of the discrete cellular components of a transwell BBB model comprising HUVECs, astrocytes, pericytes. Our results demonstrate that direct infection on the BBB model does not modulate paracellular permeability. Also, our results show that SARS-CoV-2 utilizes clathrin and caveolin-mediated endocytosis to traverse the BBB resulting in direct infection of the brain-side of the BBB model with minimal endothelial infection. In conclusion, the BBB is susceptible to SARS-CoV-2 infection in multiple ways including direct infection of endothelium, astrocytes, and pericytes involving ACE2 and/or DPP4 and the blood-to-brain transcytosis, which is a stochastic event that does not require the presence of host receptors.Up to 30% of individuals with mild to severe disease develop long COVID, exhibiting diverse neurologic symptoms including dementias. However, there is a paucity of knowledge of molecular brain markers and whether these can precipitate the onset of Alzheimer’s disease (AD). Herein, we report the brain gene expression profiles of severe COVID-19 patients showing increased expression of innate immune response genes and genes implicated in AD pathogenesis. The use of a mouse-adapted strain of SARS-CoV-2 (MA10) in an aged mouse model shows evidence of viral neurotropism, prolonged viral infection, increased expression of p-tau particularly in the brain parenchyma adjacent to CD31+ staining. Brain histopathology shows AD signatures including increased tau-phosphorylation, tau-oligomerization in aged MA10 infected mice. The results of gene expression profiling of SARS-CoV-2-infected and AD brains and studies in the MA10 aged mouse model taken together provide evidence suggesting that SARS-CoV-2 infection alters expression of genes in the brain associated with the development of AD.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy (Ph.D.)
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Medicine
Grantor
University of South Florida
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Martinez, Taylor E.
Contributors dc:contributor
  • Subhra Mohapatra, Ph.D.
  • Paula Bickford, Ph.D.
  • Alison Willing, Ph.D.
  • Jerome Breslin, Ph.D.
  • Andreas Seyfang, Ph.D.

Subjects

dc:subject × 7

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.usf.edu/etd/10531

Chain of custody

source
Harvested from
University of South Florida
Base URL
digitalcommons.usf.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Martinez, Taylor E.. SARS-CoV-2 Neurotropism: Understanding Effects at the Blood-Brain Barrier and Hematogenous Neuroinvasiveness. Dissertation thesis, University of South Florida, 2024. https://digitalcommons.usf.edu/etd/10531